Chapter title |
Cell Microencapsulation
|
---|---|
Chapter number | 1 |
Book title |
Cell Microencapsulation
|
Published in |
Methods in molecular biology, January 2017
|
DOI | 10.1007/978-1-4939-6364-5_1 |
Pubmed ID | |
Book ISBNs |
978-1-4939-6362-1, 978-1-4939-6364-5
|
Authors |
de Vos, Paul, Paul de Vos Ph.D., Paul de Vos |
Editors |
Emmanuel C. Opara |
Abstract |
The principle of immunoisolation of cells is based on encapsulation of cells in immunoprotective but semipermeable membranes that protect cells from hazardous effects of the host immune system but allows ingress of nutrients and outgress of therapeutic molecules. The technology was introduced in 1933 but has only received its deserved attention for its therapeutic application for three decades now.In the past decade important advances have been made in creating capsules that provoke minimal or no inflammatory responses. There are however new emerging challenges. These challenges relate to optimal nutrition and oxygen supply as well as standardization and documentation of capsule properties.It is concluded that the proof of principle of applicability of encapsulated grafts for treatment of human disease has been demonstrated and merits optimism about its clinical potential. Further innovation requires a much more systematic approach in identifying crucial properties of capsules and cellular grafts to allow sound interpretations of the results. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 28 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 6 | 21% |
Other | 4 | 14% |
Researcher | 4 | 14% |
Student > Master | 4 | 14% |
Student > Bachelor | 3 | 11% |
Other | 2 | 7% |
Unknown | 5 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 6 | 21% |
Agricultural and Biological Sciences | 6 | 21% |
Medicine and Dentistry | 4 | 14% |
Chemistry | 2 | 7% |
Business, Management and Accounting | 1 | 4% |
Other | 4 | 14% |
Unknown | 5 | 18% |